Cardiac prosthetic devices are used to replace damaged or diseased natural valves of the heart. These devices increase the survival rate and improve the quality of life in most patients. The cardiac prosthetic devices encompass heart valves as well as pacemakers. An artificial heart valve is a device implanted in the heart of a patient with valvular heart disease. There are three main types of artificial heart valves: the mechanical, the biological, and the tissue engineered valves. Cardiac pacemaker devices are small, battery-operated devices that senses heart beating irregularities and sends a signal to heart to makes it beat at the adequate pace. A variety of heart valves and pacemaker available in the market are mechanical heart valves, tissue heart valves, transcatheter heart valves, implantable pacemaker and external pacemaker.
The global cardiac prosthetic devices market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global cardiac prosthetic devices market segmentation is based on device or product types (heart valves, mechanical heart valves, tissue heart valves, stented tissue valve, transcatheter heart valves, pacemaker, implantable pacemaker, single-chamber battery pacemaker, dual-chamber battery pacemaker, triple-chamber battery pacemaker, external pacemaker).
The global cardiac prosthetic devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiac prosthetic devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cardiac prosthetic devices market and included in this report are Abbott Laboratories, Boston Scientific, Medtronic, Inc., St. Jude Medical and others.